U.S. flag

An official website of the United States government

Display Settings:

Format
Sort by

Send to:

Choose Destination

Links from Books

Items: 4

1.
Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
Tine A. Bækdal, Mette Thomsen, Viera Kupčová, Cilie W. Hansen, Thomas W. Anderson
J Clin Pharmacol. 2018 Oct; 58(10): 1314–1323. Published online 2018 Apr 25. doi: 10.1002/jcph.1131
PMCID:
PMC6175428
AbstractArticlePDF–646K
2.
Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial
Helena W Rodbard, Ildiko Lingvay, John Reed, Raymond de la Rosa, Ludger Rose, Danny Sugimoto, Eiichi Araki, Pei-Ling Chu, Nelun Wijayasinghe, Paul Norwood
J Clin Endocrinol Metab. 2018 Jun; 103(6): 2291–2301. Published online 2018 Apr 23. doi: 10.1210/jc.2018-00070
PMCID:
PMC5991220
AbstractArticle
3.
Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial
Melanie Davies, Thomas R. Pieber, Marie-Louise Hartoft-Nielsen, Oluf K. H. Hansen, Serge Jabbour, Julio Rosenstock
JAMA. 2017 Oct 17; 318(15): 1460–1470. Published online 2017 Oct 17. doi: 10.1001/jama.2017.14752
PMCID:
PMC5817971
AbstractArticle
4.
Effects of once‐weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
John Blundell, Graham Finlayson, Mads Axelsen, Anne Flint, Catherine Gibbons, Trine Kvist, Julie B. Hjerpsted
Diabetes Obes Metab. 2017 Sep; 19(9): 1242–1251. Published online 2017 May 5. doi: 10.1111/dom.12932
PMCID:
PMC5573908
AbstractArticlePDF–1.4M

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center